Vol. 6, Issue 2, Part A (2024)

In this review, the influence of vitamin D deficiency on CVD in patients with primary care settings shall follow observational studies in addition to clinical trials, as well as the mechanism and guidelines of each type. Cross-sectional research can also support that deficiency to vitamin D appears to be related to hypertension, CAD and heart failure. The mechanisms that were proposed are inflammation, endothelial dysfunction, and alterations in calcium regulation. Several clinical trials have been conducted to assess the effect of vitamin D supplementation in the cardiovascular diseases, and these have produced an inconclusive improvement in blood pressure but no significant effect on major cardiovascular incidences. According to the present diet charts it is advisable to consume vitamin D in range of 400 to 2000 IU daily based on age and other health conditions.
Professional organisations promote client-tail specifics which may include issues to do with sunlight, diet and supplementation. Further investigations should, therefore, aim at determining particular patients’ populations that may require vitamin D supplementation most and determine more on the possible cardiovascular impacts of vitamin D. Therefore, based on the present study, it is possible to conclude that vitamin D deficiency is associated with an elevated CVD risk; however, it requires adequately powered trials to elucidate its role in the management of CVD. This study should be used to inform primary care providers that vitamin D levels should be included in practical strategies for cardiovascular risk assessment and control.